High Volume Movers: Twitter, Sanchez Energy, Gold Fields, More

Page 2 of 2

Railroad Reports Mixed Earnings

Kansas City Southern (NYSE:KSU) shares are 1.6% in the red after the railroad operator reported EPS of $1.22 on revenue of $569 million for the second quarter. The results beat estimates by $0.18 per share on the bottom-line but missed by $3.96 million on the top-line. Revenue fell by 2.9% year-over-year, largely caused by a 6% drop in consumer products shipment revenue and a 16% drop in energy shipment revenue. Total care load volumes were flat, however, at around 537,300. Ken Fisher’s Fisher Asset Management was a top shareholder of Kansas City Southern (NYSE:KSU) at the end of June, owning 687,393 shares.

Follow Kansas City Southern (NYSE:KSU)

Twitter Expands its Streaming Video Content

In its quest to monetize its user base, Twitter Inc (NYSE:TWTR) has struck a deal with the NBA to stream new shows related to basketball. According to the deal, the NBA will produce two shows, a weekly pregame series and another whose content is still to-be-decided, which Twitter will stream on its site. The deal does not include digital rights to stream actual basketball games however. Twitter bulls hope the streaming content will help increase Twitter’s ad sales. 27 funds in our system had a bullish position in Twitter Inc (NYSE:TWTR) as of March 31, down by three funds quarter-over-quarter.

Follow Twitter Inc. (NYSE:TWTR)

ZIOPHARM Clarifies on Patient Death

Traders are watching ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) today (whose shares opened sharply higher but are now up by only 0.8%) after the biotech provided an update on the company’s Phase 1 study of Ad-RTS-hIL-12 + orally administered veledimex. According to the update, the widely publicized death of a trial participant, which resulted from intracranial hemorrhage in the third cohort of the study was “deemed unrelated to study drug” according to the study’s Safety Review Committee. The study remains open for enrollment. The number of funds that we track with holdings in ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) fell by three quarter-over-quarter to nine as of the end of March.

Follow Alaunos Therapeutics Inc. (NASDAQ:TCRT)

Disclosure: None

Page 2 of 2